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We determined the cellular distribution and the amount of 
chromogranin A in endocrine cells of bovine pancreas using a 
polyclonal antibody against bovine adrenomedullary chro-
mogranin A. The relative amounts of chromogranin A in 
the different cells of the endocrine pancreas were determined 
by computer-assisted analyses of the optical densities of the 
immunoreactivities in the stained sections. More than 80% of 
the immunoreactive chromogranin A was located in the pan-
creatic B-cells. In immunoblots of acid tissue extracts, only 
one chromogranin A band (MW 74 K D ) was observed. Quan-
tification of the immunoblots revealed that 3 [ig of chro-
mogranin A and 918 ug of insulin were present per gram 
pancreas (wet weight), equivalent to a molar ratio of 460 
umol chromogranin A per mol insulin. (J Histochem 
Cytochem 36:467-472, 1988) 
KEY WORDS: Chromogranin A; Pancreatic islet (bovine); B-cells; Im-
munohistochemistry; Immunoblots; Quantification. 
Introduction 
Chromogranin A is the main component of the family of highly 
acidic proteins that are co-stored and co-released with the catechola-
mines from adrenomedullary chromaffin cells (Winkler et al., 1986; 
Blaschko et al., 1967). Recent investigations have shown that chro-
mogranin A is also widely distributed in other endocrine tissues, 
such as the pancreatic islet cells (cf. Grube et al., 1986; Cohn et 
al., 1984; Wilson and Lloyd, 1984; O'Connor, 1983). Immuno-
histochemical studies of bovine endocrine pancreas have demon-
strated that chromogranin A is present in cells producing insulin 
(B-cells), glucagon (A-cells), and somatostatin (D-cells) and in a 
few cells containing pancreatic polypeptide (PP-cells) (Yoshie et al., 
1987; Ehrhart et al., 1986). Chromogranin A is co-stored in the 
same secretory granules as the established hormones (Ehrhart et 
al., 1986). 
A hormonal role for chromogranin A has yet to be established. 
Within the adrenomedullary chromaffin secretory granules, chro-
mogranin A is presumably involved in osmotic pressure regulation 
(Helle et al., 1985) and in the binding of Ca 2 + (Reiffen and Gratzl, 
1986a, 1986b; Bulendaand Gratzl, 1985). More recently, chromogra-
nin A has been shown to contain a sequence of amino acid residues 
(Eiden, 1987; Huttner and Benedum, 1987; Benedum et al., 1986; 
Iacangelo et al., 1986) that appears homologous to pancreastatin, 
1 Supported by Deutsche Forschungsgemeinschaft (Gr 681) and by For-
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2 Correspondence to: Prof. Dr. M. Gratzl, Abteilung Anatomie und 
Zellbiologie der Universität Ulm, Postfach 4066, D-7900 Ulm, FRG. 
which inhibits glucose-stimulated insulin secretion in rat pancreas 
(Tatemoto et al., 1986). Therefore, a role for chromogranin A in 
the regulation of hormone secretion is likely. 
For further elucidation of the functional aspects of the pancreatic 
chromogranin A, it is essential to quantify this protein relative to 
the well-established hormones. In the present study we report on 
the amounts of chromogranin A relative to the insulin content of 
the pancreatic islet and on the localization of chromogranin A pri-
marily to the insulin-storing B-cells. 
Materials and Methods 
Immunohistochemistry. The immunohistochemical stainings were per-
formed in serial semi-thin sections cut at 0.25 jam and 0.5 urn from tissue 
blocks that had been freeze-dried, fixed by vapor-phase /^-formaldehyde, 
and embedded in epoxy resin (Araldite). Details of the methods applied 
have been published previously (Ehrhart et al., 1986; Grube and Kusumoto, 
1986). The antisera used included anti-insulin (A 564; Dakopatts, Ham-
burg, FRG) diluted 112000, anti-glucagon (A 565; Dakopatts) diluted 13000, 
anti-somatostatin (kindly provided by Dr. Etzrodt, Ulm, FRG) diluted 
1'4000, anti-bovine pancreatic polypeptide (bPP; from Dr. Chance, Indi-
anapolis, IN) diluted K8000, and anti-chromogranin A (CGA; provided 
by Dr. D. Aunis, Strasbourg, France) diluted 1*16,000. The serial semi-thin 
sections were sequentially immunostained for chromogranin A and the es-
tablished pancreatic hormones by the peroxidase-antiperoxidase (PAP) tech-
nique of Sternberger (1986). 
Quantitative Immunocytochemistry. Taking into account the basic 
prerequisites for quantification in immunocytochemistry (see Sternberger, 
1986), we developed a technique for quantitative determinations of opti-
cal densities in immunoperoxidase-stained semi-thin sections by computer-
assisted analyses. The principles of the present method have been pub-
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lished previously (Grube and Kusumoto, 1986), and details will be pub-
lished elsewhere (Grube et al., in preparation). Briefly for quantification 
we found the most useful sections to be semi-thin sections, cut at 0.25 \itn, 
which were immunostained by highly diluted antisera using a standardized 
immunohistochemical protocol. Optical density measurements were per-
formed with the "Interactive Image Analysis System IBAS" (Zeiss-Kc*ntron, 
FRG) equipped with a Photomicroscope II (Zeiss, FRG) and a video cam-
era. The regions or cells to be measured were entered into the system at 
a final magnification of K1600. The corresponding images were processed 
by a 15-step measuring program; optical densities were given as differen-
tial histograms in arbitrary units (0 = black, 255 = white; see Figure 2). 
The densities of chromogranin A immunoreactivities were determined in 
174 endocrine cells which, in appropriately immunostained adjacent semi-
thin sections, had been identified as 103 B-cells, 47 A-cells, and 24 D-cells. 
Immunochemical Analyses. Fresh pancreatic tissues from calves were 
obtained at the local slaughterhouse in Ulm. The tissues were placed in an 
ice-cold medium (20 mM Mops, 0.5 mM EGTA, 340 mM sucrose, 1 mM 
PMSF, pH 7.3) and transported to the laboratory. Chromogranin extrac-
tion was carried out in acidic medium to prevent proteolysis. The tissue 
was homogenized at approximately pH 1 (10 g tissue in 5 ml medium + 
20 ml 1 N HCl) using an Ultra-Turrax (Janke and Kunkel KG; Stetten, FRG) 
and was centrifuged at 100,000 x g a v for 30 min at 4°C. The supernatant 
was used for SDS-PAGE. 
Soluble proteins of chromaffin granules were isolated as described pre-
viously (Reiffen and Gratzl, 1986a). For quantification of pancreatic chro-
mogranin A, chromaffin vesicle content was used as reference; 40% of its 
protein is chromogranin A (see Winkler and Westhead, 1980). A calibra-
tion curve was constructed using dilutions containing 1.2 u.g/ml-15 Hg/ml 
of protein. The reference probes and the pancreatic extracts were dissolved 
in extraction medium containing 5% mercaptoethanol, 2% SDS, 0.001% 
bromphenol blue and 10% sucrose in 62.5 mM Tris-HCI, pH 6.8. Twenty |il 
of each sample were subjected to SDS-PAGE (Laemmli, 1970) in 11% acryl-
amide gels. Immunoblotting was carried out following the method of Bur-
nette (1981): The proteins were transferred to nitrocellulose (Schleicher and 
Schüll; Dassel, FRG) in the electrode buffer containing 25 mM Tris, 192 
mM glycine, 20% methanol, pH 8.3, at 15 V for 16-18 hr. The nitrocellu-
lose sheets were incubated in TBS-Tween (150 mM NaCl, 50 mM Iris, 0.05% 
Tween-20, pH 7.6) containing 2.5% lipid-free instant milk instead of 5% 
BSA as blocking reagent, four times for 5 min at room temperature, and 
were washed for 5 min in TBS-Tween containing 0.5% instant milk. The 
sheets were then incubated overnight at 4°C with the rabbit anti-bovine 
chromogranin A antiserum diluted K5000 in TBS-Tween. The antiserum, 
characterized in a previous investigation (Ehrhart et al., 1986), was kindly 
provided by M.F. Bader and D. Aunis (Centre de Neurochimie, Strasbourg). 
The nitrocellulose was washed four times for 15 min in TBS-Tween and 
was then immersed in TBS-Tween containing 1 uCi/ml of iodinated pro-
tein A for 1 hr (prepared according to Greenwood et al., 1963, using 1 2 5 I ) . 
After washing in TBS-Tween three times for 1 hr, the nitrocellulose was 
dried and exposed to Kodak X Ornat AR film overnight. For quantifica-
tion, the labeled bands were cut out of the nitrocellulose and counted for 
radioactivity in a gamma counter. The values obtained for the pancreatic 
extracts were compared with the calibration curve constructed using bo-
vine chromaffin vesicle contents. 
Insulin extraction was carried out in acidified ethanol (Romans et al., 
1940): 5 g of pancreatic tissue were homogenized in 50 ml of acid/alcohol 
solution (80% ethanol, 1.5% cone. HCl (v/v), kept for 1 hr on ice, soni-
cated for 5 min, and centrifuged for 30 min at 100,000 x g a v. The insu-
lin content of the supernatant was determined using a radioimmunoassay 
(Isotopen-Diagnostik; Dreieich, FRG). Protein was determined by the 
method of Lowry (Lowry et al., 1951), using BSA as standard. 
Results 
Confirming our previous findings (Yoshie et al., 1987; Ehrhart et 
al., 1986), chromogranin A immunoreactivities were regularly found 
in B-, A-, and D-cells, whereas only a minority of PP-cells showed 
less dense immunostaining. In sections immunostained by highly 
diluted chromogranin A antiserum (1*16,000), it was obvious that 
most of the B-cells were heavily immunoreactive and that A-cells 
Figure 1. Three serial semi-thin (0.25 urn) sections through a bovine pancreatic islet. Sections were immunostained for chromogranin A (A), glucagon (B), and 
insulin (C). All glucagon and insulin cells contain chromogranin A immunoreactivities. Glucagon cells (arrows in A and B) are less densely stained than insulin 
cells. Phase-contrast microscopy. Original magnification x 495. Bar = 30 \im. 
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Figure 2. Computer-assisted analyses of optical density of chromogranin A immunoreactivities in bovine pancreatic insulin and glucagon cells. Two serial semi-thin 
(0.25 \im) sections were immunostained for chromogranin A (A) and for insulin (B). The histogram in (C) corresponds to the whole visual field as shown in (A). 
The histogram in (D) depicts the optical densities in non-immunoreactive areas (= background staining). Optical densities were measured in four endocrine cells, 
ndicated by 1, 2, 3, and 4 (A). Cells 1, 2, and 3 correspond to insulin cells, as shown in (B); cell 4 is a glucagon cell, as identified in an adjacent semi-thin section 
immunostained for glucagon (not shown). Among the insulin cells, the densities of chromogranin A immunoreactivities are heterogeneous. (E) Histogram of cell 
1, mean value of the optical density 118 (arbitrary units). (F) Histogram of cell 2, mean value 126. (G) Histogram of cell 3, mean value 145. (H) Histogram of cell 
4, mean value 149. (A, B): brightfield illumination. Original magnification x 1125. Bar = 10 | i m . 
were less densely stained (Figure 1). Likewise, D-cells were faintly 
stained (not shown). 
At higher magnifications (Figures 2A and 2B), B-cells turned 
out to be heterogeneous in their densities of chromogranin A im-
munoreactivities (Figures 2E-2G, Figure 3). Chromogranin A im-
munoreactivities in A- and D-cells were weaker and more uniform 
(Figures 2A and 2H, Figure 3). Therefore, as observed immuno-
histochemically and quantitatively, chromogranin A in the pan-
creas is mainly localized to B-cells. 
With the antibody raised against bovine chromogranin A, a 
strong reaction was obtained in the immunoblots. The main im-
munoreactive bands of the adrenomedullary vesicle content and 
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Figure 3. Optical densities of chromogranin A immunoreactivities in bovine pan-
creatic insulin (B), glucagon (A), and somatostatin (D) cells, analyzed accord-
ing to the method as illustrated in Figure 2. Mean values ± CEM, given in ar-
bitrary units, for the endocrine cell types were: 124.2 (14.4) for B-cells (n = 103); 
153.4 (7.1) for A-cells (n = 47); 165.2 (7.3) for D-cells (n = 24). Background stain-
ing (N = "noise"), 173.1 (5.4). 
of pancreatic extracts moved identically. Both have an apparent mo-
lecular weight of 74 K D . In the adrenal medulla, a band of about 
60 K D is also present. This band is not prominent in the pancreas 
(Figure 4). 
For quantification, nitrocellulose strips containing the two ma-
jor chromogranin A bands (74 K D and 60 K D ) were cut out (Figure 
5) and counted. The radioactive labeling was logarithmically propor-
tional to the bovine chromaffin granule protein, in the range of 
2.5 Lig protein/ml to 15 Hg protein/ml (Figure 2). 
Using this standard curve, 96.7 ng chromogranin A/mg pro-
tein (±24.1; n = 12) was found in the pancreatic extracts. Per gram 
wet weight, the pancreas contained 3.2 Lig chromogranin A (±1.3 
fig; n = 12) and 918 Lig insulin (±65.9 Hg; n= 12). Therefore, 
the bovine pancreas contained 3.5 Hg chromogranin A per mg of 
insulin (Table 1). 
Chromogranin A has an apparent molecular weight of 74 K D 
in SDS-PAGE; however, an actual molecular weight of 48 K D has 
been obtained from sequence analyses of the cDNA encoding bo-
vine chromogranin A (Benedum et al., 1986; Iacangelo et al., 1986). 
Therefore, on the molar level the endocrine pancreas contains 460 
|imol chromogranin A per mol insulin. 
Discussion 
Our analysis of the chromogranin A immunoreactivities of pan-
creatic endocrine cells indicates that chromogranin A is mainly local-
ized in the insulin-containing B-cells. Taking into account that about 
70-80% of the islet cells in bovine pancreas are accounted for by 
B-cells (Falkmer et al., 1984), it seems reasonable to assume that 
most of the pancreatic chromogranin A is co-stored with insulin 
in the secretory granules of the B-cells. Our quantifications indi-
cate a ratio of chromogranin A:insulin of 0.35% by weight for the 
whole tissue, i.e., the B-cells account for about 3.0 jig chromogra-
nin A per mg of stored insulin. From the work of Hutton (1984), 
it is known that the secretory granules in rat B-cells contain about 
500 jig insulin per mg of protein, suggestive of a chromogranin 
A concentration of 0.15% by weight of granule protein. Since rat 
insulin-containing secretory granules contain about 46 nmol Ca 2 + 
per mg of protein (Andersson et al., 1982), this would give a ratio 
of Ca2+:chromogranin A of 33 Limol/mg. Such a ratio is more than 
205 H 
116 
974 
6 6 -
4 5 -
2 9 -
2 0 -
A B 
Figure 4. Immunoblotting of soluble proteins of bovine chromaffin vesicles and 
of an extract of bovine pancreas. Samples were subjected to PAGE (11% acryl-
amide) followed by blotting and immunostaining with the chromogranin A an-
tiserum. (A) Chromaffin vesicle content, 0.29 ng protein; (B) pancreatic extract, 
100 | ig protein. 
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100-fold greater than the maximal binding of Ca2 + to adrenomedul-
lary chromogranin A (Reiffen and Gratzl, 1986a, 1986b), which 
indicates that calcium binding proteins other than chromogranin 
A may also be present in the periphery of the protein core of the 
insulin-storing granules to account for the peripheral concentra-
tion of Ca 2 + (Ehrhart et al., 1986; Lenzen and Klöppel, 1984; Ravaz-
zola et al., 1976). 
The glandular content of insulin presently obtained (918 \ig 
per g wet weight of pancreatic tissue) is in accordance with the value 
reported by Burgermeister et al. (1975). The islets represent about 
5% of the total tissue weight (Bonner-Weir and Like, 1980). Con-
sequently, the average concentration of insulin in the islet would 
be approximately 3 mmol/liter. Analogously, the content of chro-
mogranin A (3.2 fig per g wet weight; Table 1) would correspond 
to 1.4 (imol/liter, assuming a MW of 48 K D (Benedum et al., 1986; 
Iacangelo et al., 1986). Tatemoto et al. (1986) reported on the in-
hibitory effects of pancreastatin on glucose-induced insulin secre-
tion at peptide concentrations of 10 nmol/ liter. Hence, i f no more 
than 1% of pancreatic chromogranin A was released, processed to 
yield its pancreastatin-like sequence, and distributed throughout 
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Figure 5. Quantification of chromogranin A. (A) Immunoblotting of the two main 
bands of chromaffin vesicle content. Samples contained 290 ng, 145 ng, 73 
ng, 48 ng, 36 ng, 22 ng protein/slot. They were subjected to PAGE (11% acryl-
amide) followed by blotting and immunostaining with the chromogranin A an-
tiserum. (B) Calibration curve for chromogranin A. The labeled bands were cut 
out of the nitrocellulose and counted in a gamma counter. 
Table 1. Concentration of chromogranin A (14 KD) and insulin 
in bovine pancreasa 
Chromogranin A Insulin 
per gram per gram 
wet weight wet weight Chromogranin A |imol chromogranin A 
(n = 12) (n = 12) per mg insulin per mol insulin 
3.2 ug/g ( ± 1-3) 22.03 U/g 3.5 ug/mg 460 nmol/mol 
( ± 1 . 6 4 ) 
918 ug/g 
J Data are expressed as the mean ± SEM of the number (n) of experiments. 
the whole islet tissue, its concentration would be in the range 
reported to inhibit insulin secretion. 
With the present anti-bovine chromogranin A serum, the im-
munoreactivity was associated with the 74 K D molecular form of 
pancreatic chromogranin A (see Results). Other groups have found 
chromogranin A-immunoreactive proteins of about 20 K D in ex-
tracts of bovine and rat pancreatic tissue (Hutton et al., 1985, 1987a, 
1987b; Nolan et al., 1985), with little or no unprocessed forms pres-
ent. However, when proteolysis is avoided by addition of an inhibi-
tor of proteolysis and homogenization in acid medium (see Methods), 
the unprocessed 74 K D chromogranin A form dominates. Synthesis 
and storage of chromogranin A in its high molecular weight form (74 
K D ) by the pancreatic endocrine cells have also been found with 
another chromogranin A antiserum (Yoshie et al., 1987). In the 
latter study, possible proteolytic breakdown by endogenous pro-
teases was avoided by immediate heating of the extracts. Despite 
these precautions, a processed form of secretogranin I I (chromogra-
nin C) has been detected in the same samples. This indicates that 
another type of chromogranin, which is present mainly in the pan-
creatic polypeptide-containing cells of the pancreatic islet, is effec-
tively processed (Yoshie et al., 1987). 
Further analysis of the cellular distribution and processing of 
the chromogranin/secretogranin family in the pancreatic islet cells 
may provide a molecular basis for understanding of their role in 
endocrine secretory processes. 
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